Abortion drug could help reduce risk of breast cancer, group of medics says
Briefly

Mifepristone, a drug used in medical abortions, shows promise as a preventative treatment for high-risk women against breast cancer. Stigma surrounding mifepristone restricts pharmaceutical investigations into its effectiveness, despite three previous studies suggesting its ability to slow cancerous cell growth. The drug's association with abortion complicates research funding and trials needed to explore its potential benefits. Experts argue that the successful use of mifepristone in medical abortions should not obstruct research into other areas where it could significantly benefit public health, particularly as breast cancer is the most common female cancer globally.
Mifepristone shows promise in slowing down the growth of cancerous cells, particularly in women at high risk of breast cancer, according to several studies.
Despite evidence from three studies suggesting mifepristone may help, stigma and its association with abortion restrict further research into its potential benefits for breast cancer prevention.
Read at www.theguardian.com
[
|
]